Latest Breaking News On - Alnylam pharmaceuticals - Page 12 : comparemela.com

Alnylam Pharmaceuticals (NASDAQ:ALNY) Releases Quarterly Earnings Results, Beats Expectations By $0 23 EPS

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported ($0.52) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.75) by $0.23, Briefing.com reports. The firm had revenue of $494.33 million for the quarter, compared to analyst estimates of $428.01 million. During the same […]

William blairCantor fitzgeraldNews ratings for alnylam pharmaceuticals dailyAlnylam pharmaceuticals company profileEarnings history for alnylam pharmaceuticalsJpmorgan chase coAlnylam pharmaceuticals incAlnylam pharmaceuticalsAlnylam pharmaceuticals stockGoldman sachs groupGet free reportAlnylam pharmaceuticals dailyNasdaq alny

Alnylam Pharmaceuticals (NASDAQ:ALNY) Issues Earnings Results

Alnylam Pharmaceuticals (NASDAQ:ALNY) Issues Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cantor fitzgeraldEarnings history for alnylam pharmaceuticalsAlnylam pharmaceuticals incRoyal bankAlnylam pharmaceuticalsJpmorgan chase coGoldman sachs groupAlnylam pharmaceuticals tradingNeedham companyNews ratings for alnylam pharmaceuticals dailyGet free reportAlnylam pharmaceuticals daily

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Chardan Capital

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Chardan Capital
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

William blairHedge funds weigh in on alnylam pharmaceuticalsGoldman sachs groupAlnylam pharmaceuticalsAlnylam pharmaceuticals incCantor fitzgeraldAlnylam pharmaceuticals tradingNews ratings for alnylam pharmaceuticals dailyQuent capitalJpmorgan chase coAllspring global investments holdingsV square quantitative managementInvestment managementAnalyst recommendations for alnylam pharmaceuticalsChardan capitalFree report

Alnylam Pharmaceuticals (ALNY) Buy Rating Reaffirmed at Chardan Capital

Alnylam Pharmaceuticals (ALNY) Buy Rating Reaffirmed at Chardan Capital
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William blairAlnylam pharmaceuticalsAlnylam pharmaceuticals incEp wealth advisorsRoyal bankOppenheimer coHarbor capital advisors incAlnylam pharmaceuticals company profileAnalyst recommendations for alnylam pharmaceuticalsInstitutional investors weigh in on alnylam pharmaceuticalsWells fargo companyAlnylam pharmaceuticals stock performanceEnvestnet portfolio solutions incJpmorgan chase coNews ratings for alnylam pharmaceuticals dailyCommerce bank

StockNews com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Buy

StockNews.com upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a hold rating to a buy rating in a report issued on Monday morning. A number of other analysts have also commented on the stock. BMO Capital Markets restated an outperform rating and set a $234.00 price target on shares of Alnylam Pharmaceuticals in […]

William blairAllspring global investments holdingsInvestment managementAlnylam pharmaceuticals incAnalyst recommendations for alnylam pharmaceuticalsAlnylam pharmaceuticalsHedge funds weigh in on alnylam pharmaceuticalsRoyal bankAlnylam pharmaceuticals stockQuent capitalNeedham companyNews ratings for alnylam pharmaceuticals dailyFree reportModerate buyGet free reportGlobal investments holdings